- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 534-548 of
645 results
1666 Exhibit: E mail string, initiated on August 10, 2017
Document
IPR2017-00190, No. 1666 Exhibit - E mail string, initiated on August 10, 2017 (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
2116 Exhibit: Kaken Exhibit 2116 REDACTED VERSION
Document
IPR2017-00190, No. 2116 Exhibit - Kaken Exhibit 2116 REDACTED VERSION (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
1517 Exhibit: Label for Sporanox¿¿ itraconazole capsules, Janssen Pharmaceutica...
Document
IPR2017-00190, No. 1517 Exhibit - Label for Sporanox¿¿ itraconazole capsules, Janssen Pharmaceutical Company, NDA 20 083 (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1501 Exhibit: Onychomycosis
Document
IPR2017-00190, No. 1501 Exhibit - Onychomycosis (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
2200 Exhibit: Kaken Exhibit 2200
Document
IPR2017-00190, No. 2200 Exhibit - Kaken Exhibit 2200 (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
1511 Exhibit: PUBLIC VERSION Declaration of John C Staines, Jr in Support of Pet...
Document
IPR2017-00190, No. 1511-2 Exhibit - PUBLIC VERSION Declaration of John C Staines, Jr in Support of Petitioner¿¿¿s Reply to Patent Owner¿¿¿s Response (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1604 Exhibit: Exhibit 1604a Valeant Pharmaceuticals International, Inc, US Securit...
Document
IPR2017-00190, No. 1604 Exhibit - Exhibit 1604a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2012...
|
|
Cite Document
1670 Exhibit: Declaration of Aydin H Harston in Support of Petitioners¿¿¿ Response ...
Document
IPR2017-00190, No. 1670 Exhibit - Declaration of Aydin H Harston in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 (P.T.A.B. Jan. 5,...
|
|
Cite Document
1554 Exhibit: Exhibit 1554a Valeant Pharmaceuticals International, Inc, US Securit...
Document
IPR2017-00190, No. 1554 Exhibit - Exhibit 1554a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2016...
|
|
Cite Document
1667 Exhibit: Prosecution History of US Pat App No 15,405,171
Document
IPR2017-00190, No. 1667 Exhibit - Prosecution History of US Pat App No 15,405,171 (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
2113 Exhibit: Kaken Exhibit 2113
Document
IPR2017-00190, No. 2113 Exhibit - Kaken Exhibit 2113 (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
1547 Exhibit: Exhibit 1547a Citron Research, Valeant Could this be the Pharmaceu...
Document
IPR2017-00190, No. 1547 Exhibit - Exhibit 1547a Citron Research, Valeant Could this be the Pharmaceutical Enron, For the Rest of the Story, Click Here (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
2201 Exhibit: Kaken Exhibit 2201
Document
IPR2017-00190, No. 2201 Exhibit - Kaken Exhibit 2201 (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
1588 Exhibit: Exhibit 1588a Valeant Pharmaceuticals International, Inc, US Securit...
Document
IPR2017-00190, No. 1588 Exhibit - Exhibit 1588a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 Q, for the Quarterly Period Ended June 30, 201...
|
|
Cite Document
1509 Exhibit: Declaration of Kenneth A Walters, PhD in Support of Petitioner¿¿¿s Re...
Document
IPR2017-00190, No. 1509 Exhibit - Declaration of Kenneth A Walters, PhD in Support of Petitioner¿¿¿s Reply to Patent Owner¿¿¿s Response (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
